Online Program

Health in All Policies as a Tool to Promote the Social Determinants of Health and Health Equity

Tuesday, November 5, 2013 : 2:30 p.m. - 2:45 p.m.

Julia Caplan, MPP, MPH, Public Health Institute, California Department of Public Health, Sacramento, CA

Health in All Policies is a collaborative approach to improving the health of all people by incorporating health considerations into decision-making across sectors and policy areas. But where do we start? The presenter will explore the role of collaboration in making progress toward that vision, and will introduce the 5 key elements of a Health in All Policies approach. In addition, it is critical that these collaboratives acknowledge the goals of each partner, and pursue benefits for multiple partners. The presenter will describe how mutuality, reciprocity, and trust can be cultivated between government agencies, and share examples from California's Health in All Policies Task Force on how relationships have been fostered and co-benefits have been identified to gain buy-in and support.

Learning Areas:

Chronic disease management and prevention
Planning of health education strategies, interventions, and programs
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy

Learning Objectives:
List 5 key elements of Health in All Policies. Describe how to cultivate mutuality, reciprocity, and trust in support of Health in All Policies initiatives.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have served as the project lead for the California Health in All Policies Task Force for the last year and I have staffed the Task Force for the last three years. I am a co-author of a guide on how local and state governments can use Health in All Policies to improve health and support equity.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.